July 12th, 2016

We are pleased to announce that the Golden Helix Foundation has entered an agreement with the United Arab Emirates University to become the Regional Center of the Golden Helix Foundation in the Middle East. The two entities have signed a Memorandum of Understanding for joint research and educational activities, focusing in particular in the study of founder populations. The two entities will also co-organize scientific conferences in the region, in the scientific disciplines of pharmacogenomics and personalized medicine.

June 29th, 2016

It is with great pleasure to announce that Professor Juergen Reichardt has joined the International Scientific Advisory Council of the Golden Helix Foundation.

Professor Juergen Reichardt has a long and distinguished career in gene discovery and, more recently the functional assessment of DNA variants. He was on the faculty at the University of Southern California for 13 years. He then arrived in 2005 in Australia as the Plunkett Chair of Molecular Biology (Medicine) in Sydney where he continued many of his investigations as well as branching out into new areas by establishing new collaborations in Australia particularly in relationship to complex genetic traits, especially heart disease. He served as the Head of School, Pharmacy and Molecular Sciences at James Cook University and as the Associate Dean Research for the Faculty of Medicine, Health and Molecular Sciences at James Cook University. In January 2016, Juergenl took up the position of Vice Chancellor, Research and Innovation at YachayTech University in Ecuador, the first research-intensive university in Latin America which is modelled on CalTech. Juergen Reichardt has coauthored some 150 peer-reviewed publications with some 4,000 citations. Furthermore, he has held uninterrupted external funding for some 20 years on two continents. He also serves on the Council of HuGO, the Human Genome Organization, has coorganized various international meetings, incl. the HGM 2012 (Human Genome Meeting 2012 in Sydney; Australia) and a series of PacRim Breast and Prostate Cancer Meetings in 3 different countries, he was a visiting professor at many universities, incl. Rome in 2013 and serves also on ten international editorial boards.

The Golden Helix Foundation Board of Directors and Scientific Advisory Council warmly welcomes Professor Reichardt and looks forward to closely working with him to achieve the Golden Helix Foundation aims and goals, particularly in the Latin American region.

 

June 2nd, 2016

The 17th Golden Helix Pharmacogenomics Day was successfully organized in Rotterdam, the Netherlands on May 27th, 2016 by the Golden Helix Foundation and the Erasmus University Medical Center. Overall, the conference was attended by 164 participants from over 10 countries from Europe and the United States and was under the auspices of several national and international organizations, such as the Dutch Royal Pharmacists Association, the Genomic Medicine Alliance, the International Federation of Clinical Chemistry, and others.

The 1st session included lectures related to clinical implementation of Pharmacogenomics, featuring the keynote lecture by Prof. Julie Johnson (University of Florida, Tampa, FL, USA), followed by Prof. Markus Paulmichl (Paracelsus University, Salzburg, Austria), who provided an overview of the implementation of Pharmacogenomics in Austria and Prof. Magnus Ingelman-Sundberg (Karolinska Institutet, Stockholm, Sweden), who talked about sequencing of rare variants of pharmacogenomics interest. The 2nd session provided an overview of cases, as evidence for clinical use of pharmacogenomics, focusing on TPMT genotyping for thiopurine treatment (Dr. Marieke Coenen,Radboud University, Nijmegen, the Netherlands), DPYD genotyping (Dr. Linda Henricks, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands), tamoxifen and CYP2D6 genotyping (Prof. Matthias Schwabb, Margarete Fisher Bosch Institute, Stuttgart, Germany) and SLCO1B1 and statin pharmacogenomics (Prof. Mikko Niemi, University of Helsinki, Helsinki, Finland). There were also lectures about evidence-based dosing based on genotype, by the KNMP Pharmacogenomics Working Group (Dr. Vera Deneer, den Haag, the Netherlands) and the European Medicine Agency Pharmacogenomics Working Party (Dr. Norma Anwar, London, UK). Professor George Patrinos (University of Patras, Greece) gave an update on the use of whole genome sequencing in pharmacogenomics, which followed by several company lectures that supported the event as sponsors.

In the afternoon sessions, there were lectures including the description of the Genomics England initiative by Prof. Tim Hubbard (Genomics England and Kings College London, UK), of the CPCT approach for the sequencing the tumor genome by Dr. Emile Voest (Netherlands Cancer Institute, Amsterdam, the Netherlands) and by the few European Pharmacogenomics initiatives, such as the European Society of Pharmacogenomics & Personalized Therapy, the European Pharmacogenomics Implementation Consortium (Eu-PIC; overview provided by Prof. Ron van Schaik, Erasmus MC, Rotterdam, the Netherlands) and the HORIZON2020 U-PGx project, which was presented by its coordinator, Prof. Henk-Jan Guchelaar (Leiden University Medical Center, Leiden, the Netherlands. In the latter project, the Golden Helix Foundation participates as a partner, responsible for the economic evaluation and dissemination.

March 15th, 2016

The Golden Helix Foundation proudly announces the establishment of the Golden Helix Academy, as part of the Foundation's educational activities. The Golden Helix Academy aims to establish, in concert with established academic institutions, e-learning modules related to Genomic Medicine topics, such as Public Health Genomics, Genome informatics, Economics and Health Technology Assessment in Genomics and Genethics, These modules lead to Certificates, specifically aimed for the needs of parties from developing countries.

These modules will be provided in English, as well as in local languages, where applicable.

Please click here for more information related the currently available e-Learning modules. 

October 20th, 2015

We are delighted to announce that the Golden Helix Foundation has entered an agreement with the University of Malaya to become the Regional Center of the Golden Helix Foundation in Asia-Pacific. The two entities have signed a Memorandum of Understanding for joint research and educational activities, focusing in particular on Public Health Genomics.

The first joint project will be announced in April 2016 and will be implemented in the region of Southeast Asia.

August 26th, 2015

We are excited to report that the U-PGx proposal that was submitted in the PHC-24-2015 – Piloting personalised medicine in health and care systems H2020 call has been favourably evaluated by the European Commission in stage 2 evaluations and achieved top score. The project will have a funding volume of 14,9 million Euros and a duration of 60 months. The grant agreement is expected to be finalised within the next 3 months.

The Golden Helix Foundation participates in the U-PGx project as full partner and Component Leader (Project coordinator: Prof. Henk-Jan Guchelaar; Leiden University Medical Center, the Netherlands), responsible for the economic evaluation and dissemination activities.

April 24th, 2015

Workshop: 16th Golden Helix Pharmacogenomics Day at Festival of Genomics Boston in June 22nd 2015 at 16:00-19:00

The 16th Golden Helix Pharmacogenomics Day is an educational event that aims to provide timely updates on the field of pharmacogenomics and personalized medicine to the local biomedical scientists and healthcare providers, to inform them on the application of pharmacogenomics in fields such as psychiatric disorders, oncology, and to bring together faculty members from universities and research institutes from the local scientific arena working in the field of pharmacogenomics in order to initiate collaborative projects in this field to the benefit of society.

This workshop will include:

  • Lectures by 6 speakers from the US, both from academia, industry and regulatory (NIH) backgrounds.
  • Topics will pertain to pharmacogenomics and personalized medicine
  • The Global Genomic Medicine Collaborative and the Genomic Medicine Alliance initiatives will be highlighted.

What will participants take away from this workshop?

  • The most recent trends on pharmacogenomics
  • The aims and goals of the Global Genomic Medicine Collaborative and the Genomic Medicine Alliance Initiatives
  • Collaboration and training opportunities with the faculty of the workshop

Organizing committee

George P. Patrinos, University of Patras Department of Pharmacy, Patras, Greece

Konstantinos Mitropoulos, the Golden Helix Foundation, London, UK

Speakers:

  • Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
  • Federico Innocenti, Associate Professor, University of North Carolina, Chapel Hill, NC, USA
  • Alan R. Shuldiner, Vice President, Translational Genetics, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
  • Marc S. Williams, Director, Genomic Medicine Institute, Geisinger Health System, Danville, PA,USA
  • George P. Patrinos, Associate Professor, University of Patras Department of Pharmacy, Patras, Greece
  • Deepak Voora, Assistant Professor, Duke Center for Genomic and Computational Biology, Durham, NC, USA

Enter promo code: Helix25 and get 25% off at registration.

December 2nd, 2014

Today, the Golden Helix Foundation and the Section of Pharmacogenomics and Pharmacogenetics of International Union of Basic and Clinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learning activities.

The Section of Pharmacogenomics and Pharmacogenetics is a formal section of IUPHAR, a non-profit association representing the interests of pharmacologists throughout the world and whose mission is: Better Medicines through Global Education and Research. The Section’s aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and –genomics, to evaluate the clinical impact of pharmacogenetics, to assist with the development and maintenance of drug-related pharmacogenetic databases and to create a population based “biobank” to conduct translational research in clinical pharmacogenomics.

In furtherance of their mutual interest in improving fundamental and clinical pharmacogenomics and its translation into clinical practice, the two organizations have agreed: (a) cooperate and collaborate on programs and activities of mutual interest, (b) work together to provide education symposia/workshops in developing countries and regions, and (c) foster collaborative research to better understand the genetic basis for ethnic diversity in the response to and adverse effects from medicines. Also, from time to time, the organizations may cooperate in providing speakers, programs and supports for each other’s meetings.

The cooperation between these international organizations and the closely related to the Golden Helix Foundation Genomic Medicine Alliance, are expected to catalyze their invovlement in research and educational activities in the field of Genomic Medicine.

November 3rd, 2014

The 2014 Golden Helix Symposium was co-organized in Belgrade Serbia, October 30th - November 1st, 2014, by the Golden Helix Foundation, jointly with the Institute of Molecular Genetics and Genetic Engineering. This international conference marked the official launch of the Genomic Medicine Alliance and the 1st Genomic Medicine Alliance - Public Health Genomics Prize, awarded to the work of Chondrou and coworkers, entitled "Differential molecular profiling of human hematopoietic tissues during human ontogenesis: Implications for β-type hemoglobinopathies therapeutics". This award is a joint initiative of Genomic Medicine Alliance and Karger, through its scientific journal Public Health Genomics, the Alliance's official journal.

This meeting was attended by over 250 registered speakers and participants from over 20 countries.

Next year, the Golden Helix Symposia travel to Asia, specifically in Kuala Lumpur, Malaysia for the forthcoming 2015 Golden Helix Symposium (March 11-13, 2015), which will mark the official partnership of the Genomic Medicine Alliance and the Southeast Asian Pharmacogenomics (SEAPharm) Consortium.

September 19th, 2014

The 2014 Golden Helix Summer School was successfully organized in Apollo resort hotel in Aegina island, Greece, 11-15 September 2014. The meeting was attended by more than 80 registered participants from over 20 countries and attended lectures from internationally renowned speakers from Europe, the US, Middle East and Asia, including an EMBO lecture from Prof. Doug Higgs (Oxford, UK). Two trophies were presented to Ms. Marina Bartsakoulia (Newcastle, UK) and Prof. Sonja Pavlovic (Belgrade, Serbia) for submitting the two best abstracts for this meeting.

We believe that this meeting, co-organized by the Golden Helix Foundation and the Genomic Medicine Alliance, has set a high standard and we look forward to the co-oganization of the next Golden Helix Summer School in 2016. Please check back soon for more updates.

Connect With Us

Subscribe to all RSS or just the section
you care..

RSSFacebookTwitterFlickr

Looking for Golden Helix, Inc

Our Videos

Genetic Analysis in Translational medicine:

You are here: Home News Latest News